Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K244001
    Date Cleared
    2025-05-02

    (127 days)

    Product Code
    Regulation Number
    876.1500
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    KARL STORZ Cysto-Urethro-Fiberscope (11272CU1); KARL STORZ Cysto-Urethro-Fiberscope (11272C2)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The KARL STORZ Cysto-Urethro-Fiberscope and accessories are indicated for visualization and operative access during diagnostic and therapeutic endoscopic procedures of the urinary tract including the urethra and bladder.

    Device Description

    The KARL STORZ Cysto-Urethro-Fiberscope and Accessories consists of a flexible fiber endoscope (Model Number: 11272CU1 / 11272C2) which can be used standalone or connected to compatible FDA-cleared camera heads which transfer images to compatible FDA-cleared Computer Control Units (CCUs) for the purposes of visualization and operative access during diagnostic and therapeutic endoscopic procedures of the urinary tract including the urethra and bladder.

    AI/ML Overview

    Based on the provided FDA 510(k) clearance letter for the KARL STORZ Cysto-Urethro-Fiberscope, it's clear that no clinical performance data was provided or required for this 510(k) submission. The submission relies entirely on non-clinical (bench) performance data.

    Therefore, many of the requested elements pertaining to acceptance criteria and clinical study design (e.g., sample size for test set, number of experts, adjudication method, MRMC study, standalone performance, ground truth types for clinical data) are not applicable to this particular device clearance.

    The 510(k) summary explicitly states:

    Clinical Performance Data Clinical testing was not required to demonstrate substantial equivalence to the predicate device. Non-clinical bench testing was sufficient to assess safety and effectiveness and to support substantial equivalence.

    Given this, I will describe the acceptance criteria as implied by the non-clinical tests conducted and the proof that the device met these criteria based on the information provided.


    Acceptance Criteria and Study Proving Device Meets Acceptance Criteria for KARL STORZ Cysto-Urethro-Fiberscope

    As per the submitted 510(k) summary (K244001), the substantial equivalence of the KARL STORZ Cysto-Urethro-Fiberscope was established through non-clinical performance data only. No clinical studies were conducted or required for this clearance.

    Therefore, the "acceptance criteria" are derived from the successful completion of various bench tests and compliance with recognized standards designed to ensure the safety and effectiveness of the device. The "study" proving the device meets these criteria refers to the non-clinical (bench) performance testing.

    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria for this device are implicitly tied to the successful completion and passing results of the tests conducted in accordance with the listed standards and internal design specifications. The performance is reported as meeting these standards.

    Acceptance Criterion (Implied by Test Performed)Reported Device Performance
    Biocompatibility (e.g., cytotoxicity, irritation, sensitization, systemic toxicity, chemical characterization, animal welfare)Complies with FDA 2023 biocompatibility guidance and ISO 10993 series standards (ISO 10993-1, -2, -5, -10, -11, -12, -18, -23).
    Reprocessing Validation (Cleaning and Sterilization)Complies with ANSI/AAMI/ISO 14937, ANSI/AAMI ST98, ASTM F3208-20, ISO 17664-1, ISO 22441, AAMI TIR12:2020/(R)2023, and FDA Guidance Document: Reprocessing Medical Devices in Health Care Settings. (Details on specific cleaning/sterilization efficacy were not provided in the summary, but successful validation is stated.)
    Mechanical Performance (e.g., shaft length, diameter, deflection, working channel)Meets design specifications; functionally similar to predicate device (e.g., Working shaft length: 370 mm, Deflection: 210˚ Up, 140˚ Down). Successful completion of "Bench testing – Mechanical Performance Verification" is reported.
    Optical Performance (e.g., field of view, direction of view, image quality through eyepiece)Field of view: 116˚, Direction of view: 0˚. Successful completion of "Bench testing – Optical Performance Verification" is reported.
    Photobiological SafetySuccessful completion of "Bench testing – Photobiological Safety" in compliance with IEC 62471:2006.
    Thermal SafetySuccessful completion of "Bench testing – Thermal Safety" in compliance with IEC 60601-2-18:2009.
    General Electrical SafetyCompliance with IEC 60601-2-18:2009.
    Optical Instrument StandardsCompliance with ISO 8600-3:2019 and ISO 8600-5:2020.

    2. Sample Size Used for the Test Set and Data Provenance

    • Test Set Sample Size: Not applicable. No clinical test set was used. The "test set" in this context refers to the physical units of the device subjected to bench testing. The specific number of units tested for each non-clinical performance test is not detailed in the 510(k) summary, but it would have been sufficient to meet the requirements of the cited standards and internal quality procedures.
    • Data Provenance: Not applicable for a clinical study. The non-clinical testing was conducted by KARL STORZ SE & CO. KG, which is based in Tuttlingen, Germany. The data is from laboratory (bench) testing, not patient data.

    3. Number of Experts Used to Establish Ground Truth for Test Set and Qualifications

    Not applicable. No clinical test set requiring expert ground truth establishment was used. Bench testing relies on objective measurement against predefined specifications and standard requirements, not subjective expert assessment of clinical data.

    4. Adjudication Method for the Test Set

    Not applicable. No clinical test set requiring adjudication was used.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done

    No. An MRMC study was not conducted as no clinical performance study was performed or required.

    6. If a Standalone Performance Study (Algorithm Only) Was Done

    Not applicable. This device is a medical instrument (fiberscope), not an AI algorithm. Therefore, a standalone algorithm performance study is irrelevant.

    7. The Type of Ground Truth Used

    • For Non-Clinical Testing: The "ground truth" for the bench tests is the objective, measurable performance of the device against established engineering specifications, safety standards (e.g., IEC, ISO, ANSI/AAMI), and the functional capabilities of the predicate device. This is determined through physical measurements, chemical analyses, and standardized test protocols.

    8. The Sample Size for the Training Set

    Not applicable. No clinical training set was used as this is a physical medical device (fiberscope), not an AI/ML algorithm requiring data-driven training.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable. No clinical training set was used.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1